|
|
Effectiveness of combined treatment of shensongyangxin capsule and metoprolol on atrial arrhythmia by ambulatory electrocardiography |
|
|
Abstract Objective To observe and evaluate the effectiveness of the combined treatment of shensongyangxin capsule and metoprolol on atrial arrhythmia by ambulatory electrocardiography(AECG). Methods Seventyeight patients with frequent atrial premature beats and paroxysmal atrial tachycardia were randomly divided into two groups, each with 39 cases. Patients in group A underwent a combined therapy of shensongyangxin capsule and metoprolol. They orally took 4 shensongyangxin capsules per time, 3 times per day and metoprolol at a dose of 12.5[CD*2]25 mg per time, 2 times per day. Patients in group B orally took metoprolol at a dose of 12.5[CD*2]25 mg per time, 2 times per day. After 4 weeks of treatment, AECG changes of the two groups were observed and compared. Results The improvement rate of arrhythmia in group A and B was 97.44% and 64.10%, respectively, with statistically significant difference(P<0.05). Conclusion It is obviously observed by AECG that the combined treatment of shensongyangxin capsule and metoprolol significantly strengthens the curative effect on frequent atrial premature beats and paroxysmal atrial tachycardia if compared with metoprolol alone.
|
|
|
|
|
[1] 胡发明,黄知秀.参松养心胶囊治疗冠心病心律失常有效性与安全性Meta分析[J].医药导报,2012,31(5):671-674.[2] 陈修,陈维洲,曾贵云,等.心血管药理学[M].3版.北京:人民卫生出版社,1989:456.[3] 陈新.黄宛临床心电图学[M].6版.北京:人民卫生出版社,2009:272.[4] 胡昊,唐海沁,李洁华,等.参松养心胶囊抗心律失常的疗效和安全性系统评价[J].中国循证医学杂志,2011,11(2):168-173. |
|
|
|